Search
for
Sort by
Research 241–270 of 1000+
- Low-dose oral minoxidil for androgenetic alopecia is not associated with blood pressure changes in patients also taking other antihypertensive medications: A multi-center cohort study using TriNetX
- The Effect of Medications Used in Mesotherapy on Hair Organ Culture and Culture of Dermal Papilla Cells
- How much medication is delivered in a novel drug delivery technique that uses a tattoo machine?
- Safety Considerations and Monitoring in Patients Treated with Systemic Medications for Acne
- A cross‐sectional analysis of medications used by patients reporting alopecia areata on the FDA adverse events reporting system
- 74126 GLP-1RA Medications and Alopecia: Evaluating Risk Across Diabetic and Non-Diabetic Populations
- Commonly prescribed medications associated with alopecia
- Medications affecting the insulin-like growth factor 1/growth hormone axis, including teprotumumab, somatostatin analogs, and anti-calcitonin gene-related peptide monoclonal antibodies, are associated with elevated reporting odds of alopecia in women: A pharmacovigilance study
- Medication-induced hair loss: An update
- Glucagon-like peptide-1 receptor agonist medications and hair loss: A retrospective cohort study
- 180 Impact of underlying medical conditions and medications on edema development in alopecia patients receiving low-dose oral minoxidil (LDOM)
- Topical minoxidil for nail growth: A conventional medication with a novel indication
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- Response to Mounessa et al.’s “Commonly prescribed medications associated with alopecia’’
- Discount pharmacies may save patients significant money on androgenetic alopecia medications compared to both traditional pharmacies and direct-to-consumer companies
- Increased risk of telogen effluvium with tirzepatide compared to other weight-loss medications: a retrospective cohort TriNetX database study
- Evaluating the role of COVID-19 vaccines in the landscape of medication-induced alopecia areata
- Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata
- Multi-therapies in androgenetic alopecia: review and clinical experiences
- Secondary cicatricial and other permanent alopecias
- DERMABRASION
- Cosmetic Concerns Among Ethnic Men
- Clinicoepidemiological Observational Study of Acquired Alopecias in Females Correlating with Anemia and Thyroid Function
- Origin, Clinical Presentation, and Diagnosis of Facial Hypermelanoses
- What every physician should know about polycystic ovary syndrome
- Multifactorial Classification of Male and Female Androgenetic Alopecia
- Androgenetic alopecia and COVID ‐19: A review of the hypothetical role of androgens
- Non-surgical treatments for basal cell skin cancer
- Cushing Syndrome from Percutaneous Absorption of 1% Hydrocortisone Ointment in Netherton Syndrome
- Androgenetic alopecia: Update on etiology